Medtronic PLC (MDT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $131.57B
Last updated: Nov 17, 2026 at 11:06 AM ET
Medtronic PLC (MDT) P/E Ratio & Valuation History
Medtronic (MDT) trades at 18.0x trailing earnings and 3.5x sales. Its P/E of 18.0x is above its 5-year median of 16.2x. Its forward P/E is 17.2x. The median P/E across 11 similar companies is 21.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 4.7% higher over the next year. Its free cash flow yield is 4.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 18.0x |
| Forward P/E | 17.2x |
| Price to sales | 3.5x |
| Price to book | 2.6x |
| EV/EBITDA | 15.4x |
| Price to FCF | 21.5x |
| EV/FCF | 25.8x |
| PEG | 1.9 |
| FCF yield | 4.7% |
Historical Medians
Against its 10-year medians, its P/E is 4.0% above 17.3x, its P/S is 7.9% below 3.8x and its P/B is 8.3% above 2.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 18.0x | 16.2x | 17.3x |
| P/S | 3.5x | 3.5x | 3.8x |
| P/B | 2.6x | 2.3x | 2.4x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 14.6x in 2022 to 32.0x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $96.06 | 17.1x | 3.5x | 2.5x |
| 2024 | $79.88 | 15.2x | 3.2x | 2.1x |
| 2023 | $82.38 | 15.5x | 3.4x | 2.1x |
| 2022 | $77.72 | 14.6x | 3.4x | 2.0x |
| 2021 | $103.45 | 18.7x | 4.4x | 2.7x |
| 2020 | $117.14 | 32.0x | 5.6x | 3.1x |
| 2019 | $113.45 | 21.0x | 4.9x | 3.0x |
| 2018 | $90.96 | 18.3x | 4.1x | 2.5x |
| 2017 | $80.75 | 17.4x | 3.7x | 2.1x |
| 2016 | $71.23 | 15.9x | 3.4x | 2.0x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MDT
What is MDT's forward P/E ratio?
Medtronic has a forward P/E ratio of 17.2x.
Is MDT stock overvalued?
GNG's valuation label for MDT is Fairly valued. Its P/E of 18.0x compares with a median of 21.8x across 11 similar companies.
What is MDT's price to sales ratio?
Medtronic has a price to sales ratio of 3.5x.
What is Medtronic's average P/E ratio over 5 years?
Medtronic's median P/E over the last 5 years is 16.2x, from 60 month-end values through Oct 2026.
What is MDT's PEG ratio?
Medtronic has a PEG ratio of 1.9.
MDT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts